Glucotrack Inc (GCTK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GCTK Annual Balance Sheets →
The data below summarizes Glucotrack Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1.12
Cash & Short-term Investments1.00
Other Current Assets0.26
Total Current Assets1.38
Equipment/Property/Plant Net0.10
Other Assets, Noncurrent0.02
Total Assets1.50
Liabilities
Accounts Payable, Current AC1.12
Derivative Liability LI0.00
Other Notes Payable, Current OT1.69
Other Liabilities, Current0.18
Total Current Liabilities2.99
Long-term debt0.25
Total Long-term Debt0.25
Derivative Liability, Noncurrent DE0.00
Due to Officers or Stockholders, Noncurrent0.00
Total Liabilities3.24
Stockholders' Equity
Receipts On Account Of Shares-
Common Stock Value0.01
Additional Paid In Capital Common Stock158.19
Retained Earnings / Accumulated Deficit-159.99
Accumulated Other Comprehensive Income0.05
Other Equity0.05
Common Stockholder's Equity-1.74
Total Stockholder's Equity-1.74
Liabilities & Stockholder's Equity1.50
4 historic quarters locked

Sign in to unlock the full Glucotrack Inc balance sheet history.

About Glucotrack Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038317

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.